Literature DB >> 23290889

Matched and mismatched metabolic fuels in lymphocyte function.

Alfredo Caro-Maldonado1, Valerie A Gerriets, Jeffrey C Rathmell.   

Abstract

Immunological function requires metabolic support to suit the needs of lymphocytes at a variety of distinct differentiation and activation states. It is now evident that the signaling pathways that drive lymphocyte survival and activity can directly control cellular metabolism. This linkage provides a mechanism by which activation and specific signaling pathways provide a supply of appropriate and required nutrients to support cell functions in a pro-active supply rather than consumption-based metabolic model. In this way, the metabolism and fuel choices of lymphocytes are guided to specifically match the anticipated needs. If the fuel choice or metabolic pathways of lymphocytes are dysregulated, however, metabolic checkpoints can become activated to disrupt immunological function. These changes are now shown in several immunological diseases and may open new opportunities to selectively enhance or suppress specific immune functions through targeting of glucose, lipid, or amino acid metabolism.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290889      PMCID: PMC3582857          DOI: 10.1016/j.smim.2012.12.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  88 in total

1.  Akt acutely activates the cholesterogenic transcription factor SREBP-2.

Authors:  Winnie Luu; Laura J Sharpe; Julian Stevenson; Andrew J Brown
Journal:  Biochim Biophys Acta       Date:  2011-10-08

2.  IL-7 enhances the survival and maintains the size of naive T cells.

Authors:  J C Rathmell; E A Farkash; W Gao; C B Thompson
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

3.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

4.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

5.  Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow.

Authors:  Hidefumi Kojima; Ayano Kobayashi; Daisuke Sakurai; Yumiko Kanno; Hidenori Hase; Riichi Takahashi; Yoshikazu Totsuka; Gregg L Semenza; Michail V Sitkovsky; Tetsuji Kobata
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

6.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

7.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival.

Authors:  Jessica A Wofford; Heather L Wieman; Sarah R Jacobs; Yuxing Zhao; Jeffrey C Rathmell
Journal:  Blood       Date:  2007-11-27       Impact factor: 22.113

8.  Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

Authors:  Peter Gergely; Craig Grossman; Brian Niland; Ferenc Puskas; Hom Neupane; Fatme Allam; Katalin Banki; Paul E Phillips; Andras Perl
Journal:  Arthritis Rheum       Date:  2002-01

9.  In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment.

Authors:  Akio Ohta; Rohan Diwanji; Radhika Kini; Meenakshi Subramanian; Akiko Ohta; Michail Sitkovsky
Journal:  Front Immunol       Date:  2011-07-05       Impact factor: 7.561

10.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

View more
  22 in total

Review 1.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

2.  Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Athanasios Mavropoulos; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Biomed Rep       Date:  2017-09-11

Review 3.  Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Authors:  Michael N Sack
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

4.  CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

Authors:  Shilpak Chatterjee; Anusara Daenthanasanmak; Paramita Chakraborty; Megan W Wyatt; Payal Dhar; Shanmugam Panneer Selvam; Jianing Fu; Jinyu Zhang; Hung Nguyen; Inhong Kang; Kyle Toth; Mazen Al-Homrani; Mahvash Husain; Gyda Beeson; Lauren Ball; Kristi Helke; Shahid Husain; Elizabeth Garrett-Mayer; Gary Hardiman; Meenal Mehrotra; Michael I Nishimura; Craig C Beeson; Melanie Gubbels Bupp; Jennifer Wu; Besim Ogretmen; Chrystal M Paulos; Jeffery Rathmell; Xue-Zhong Yu; Shikhar Mehrotra
Journal:  Cell Metab       Date:  2017-11-09       Impact factor: 27.287

Review 5.  From zero to sixty and back to zero again: the metabolic life of B cells.

Authors:  Munir Akkaya; Susan K Pierce
Journal:  Curr Opin Immunol       Date:  2018-10-09       Impact factor: 7.486

6.  Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.

Authors:  Asim Saha; Patricia A Taylor; Christopher J Lees; Angela Panoskaltsis-Mortari; Mark J Osborn; Colby J Feser; Govindarajan Thangavelu; Wolfgang Melchinger; Yosef Refaeli; Geoffrey R Hill; David H Munn; William J Murphy; Jonathan S Serody; Ivan Maillard; Katharina Kreymborg; Marcel van den Brink; Chen Dong; Shuyu Huang; Xingxing Zang; James P Allison; Robert Zeiser; Bruce R Blazar
Journal:  JCI Insight       Date:  2019-10-03

7.  Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus.

Authors:  Devin P Champagne; Ketki M Hatle; Karen A Fortner; Angelo D'Alessandro; Tina M Thornton; Rui Yang; Daniel Torralba; Julen Tomás-Cortázar; Yong Woong Jun; Kyo Han Ahn; Kirk C Hansen; Laura Haynes; Juan Anguita; Mercedes Rincon
Journal:  Immunity       Date:  2016-05-24       Impact factor: 31.745

Review 8.  The mTOR pathway and integrating immune regulation.

Authors:  Stephen P Cobbold
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

Review 9.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

Review 10.  Mitochondrial ROS signaling in organismal homeostasis.

Authors:  Gerald S Shadel; Tamas L Horvath
Journal:  Cell       Date:  2015-10-22       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.